CDXS Codexis, Inc. - Common Stock
$1,57
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 11, 2026
52 Haftlık Aralık
$1–$3
29% of range
Analist Derecelendirmesi
BUY
13 analysts
Fiyat Hedefi
$7
+321% upside
P/E (TTM)
-3.1
ROE
-82.8%
Net Kâr Marjı
-62.5%
Codexis, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Devamını oku
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
History
Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio.
Pharmaceutical
Codexis won the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in 2006 for its work on a building block of Lipitor. It then won a second time in 2010 for its work with Merck & Co. on the active ingredient in Januvia.
Nutrition
In 2017, the company entered a partnership with Tate & Lyle to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with Nestle to provide enzymes for metabolic disorders.
Biotherapeutics
In 2017, Codexis developed a recombinant phenylalanine ammonia-lyase (PAL) enzyme, to act as a substitute phenylalanine hydroxylase (PAH) enzyme for people who suffer from phenylketonuria. The enzyme was in-licensed by Nestle Health Sciences.
In 2020, Takeda Pharmaceutical announced a collaboration with Codexis to research and create gene therapies for rare diseases, including lysosomal storage disorders.
Life science
In June 2020, they announced a partnership with Molecular Assemblies to engineer enzymes for DNA synthesis.
Technology
Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
CDXS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.56
Piyasa Değeri
$142M
P/E (TTM)
-3.1
EPS (TTM)
$-0.50
Gelir (TTM)
$70M
Temettü Verimi
—
ROE
-82.8%
D/E Borç/Özsermaye
0.8
52 Haftlık Aralık
$1 – $3
CDXS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$70M
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-0.50
2019-12-31
→
2025-12-31
Serbest Nakit Akışı
$-24M
2016-12-31
→
2025-12-31
Marjlar
-62.5%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
CDXS
Akran Ortalaması
P/E (TTM)
-3.1
17.5
P/S (TTM) (F/S (TTM))
2.0
3.3
P/B (F/D)
2.8
2.1
EV / EBITDA
-2.8
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-5.9
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
CDXS
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-59.3%
—
Net Profit Margin (Net Kâr Marjı)
-62.5%
-56.5%
ROA
-29.6%
-17.2%
ROE
-82.8%
-41.3%
ROIC
-46.1%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
CDXS
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.8
369.6
Current Ratio (Cari Oran)
3.8
4.9
Quick Ratio (Cari Oran)
3.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
CDXS
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
18.6%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-20.2%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
0.38%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
CDXS
Akran Ortalaması
CDXS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
13 analist
- Güçlü Al 4 30,8%
- Al 6 46,2%
- Tut 3 23,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
6 analist · 2026-08-13
Medyan
$7.00
← Tüm hedeflerin altında
$1.56
Düşük
$2.00
Yüksek
$11.00
Medyan hedef
$7.00
+347,3%
Ortalama hedef
$6.58
+320,7%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.01%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.13 | $-0.14 | 0.01% |
| 31 Mart 2026 | $-0.10 | $-0.14 | 0.04% |
| 31 Aralık 2025 | $0.11 | $-0.04 | 0.15% |
| 30 Eylül 2025 | $-0.22 | $-0.15 | -0.07% |
| 30 Haziran 2025 | $-0.16 | $-0.19 | 0.03% |
| 31 Mart 2025 | $-0.25 | $-0.24 | -0.01% |
| 31 Aralık 2024 | $-0.13 | $-0.04 | -0.09% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| QSI | — | — | — | — | — | — |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
| QTRX | $297M | -2.5 | 1.1% | -77.1% | -36.4% | 46.8% |
| SEER | — | -1.4 | 17.0% | — | — | — |
| NAUT | $247M | -4.1 | — | — | -34.9% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Cost of Revenue | $9M | $16M | $13M | $38M | $22M | $14M | $16M | $13M | $14M | $10M | $7M | $10M | |
| R&D Expense | $52M | $46M | $59M | $80M | $56M | $44M | $34M | $30M | $30M | $22M | $21M | $23M | |
| SG&A Expense | $47M | $55M | $53M | $52M | $49M | $35M | $32M | $29M | $29M | $25M | $22M | $22M | |
| Operating Expenses | $112M | $118M | $138M | $173M | $127M | $93M | $81M | $72M | $73M | $57M | $50M | $54M | |
| Operating Income | $-42M | $-59M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Interest Income | $3M | $4M | $4M | $1M | $459.0K | $405.0K | $1M | $671.0K | $147.0K | $60.0K | $19.0K | $18.0K | |
| Other Non-op | $-5M | $-10M | $-12M | $124.0K | $1M | $-156.0K | $-656.0K | $-291.0K | $-92.0K | $-94.0K | · | · | |
| Pretax Income | $-44M | $-65M | $-76M | $-33M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Income Tax | $47.0K | $34.0K | $69.0K | $276.0K | $189.0K | $339.0K | $17.0K | $-37.0K | $81.0K | $-40.0K | $-338.0K | $-256.0K | |
| Net Income | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| EPS (Basic) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| EPS (Diluted) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| Shares (Basic) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| Shares (Diluted) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| EBITDA | $-36M | $-54M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M |
Bilanço 29
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $19M | $65M | $114M | $117M | $149M | $90M | $53M | $31M | $19M | $23M | $26M | |
| Short-term Investments | $27M | $54M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | $10M | $32M | $25M | $14M | $9M | $12M | $11M | $6M | $7M | $4M | |
| Inventory | $2M | $2M | $3M | $2M | $1M | $964.0K | $371.0K | $589.0K | $1M | $825.0K | $992.0K | $1M | |
| Prepaid Expense | $6M | $4M | $5M | $5M | $6M | $3M | $3M | $1M | $984.0K | $1M | $1M | $1M | |
| Other Current Assets | $500.0K | $500.0K | $600.0K | $700.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $97M | $99M | $93M | $163M | $162M | $184M | $114M | $68M | $45M | $27M | $33M | $33M | |
| PP&E (Net) | $13M | $14M | $15M | $23M | $21M | $10M | $6M | $5M | $3M | $2M | $3M | $4M | |
| PP&E (Gross) | $58M | $55M | $55M | $62M | $57M | $43M | $40M | $38M | $35M | $34M | $35M | $37M | |
| Accum. Depreciation | $45M | $41M | $39M | $40M | $36M | $33M | $33M | $33M | $32M | $32M | $32M | $31M | |
| Goodwill | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | · | · | · | · | · | · | · | · | · | $0 | $3M | $6M | |
| Other Non-current Assets | $883.0K | $1M | $1M | $350.0K | $276.0K | $294.0K | $178.0K | $1M | $302.0K | $259.0K | $310.0K | $294.0K | |
| Total Assets | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Accounts Payable | $2M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $5M | |
| Accrued Liabilities | $3M | $6M | $5M | $15M | $13M | $10M | $7M | $5M | $4M | $2M | $2M | $3M | |
| Current Liabilities | $25M | $24M | $36M | $49M | $33M | $25M | $15M | $18M | $25M | $12M | $15M | $14M | |
| Capital Leases | $30M | $28M | $12M | $38M | $44M | $22M | $25M | $61.0K | $302.0K | · | · | · | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $97M | $82M | $50M | $106M | $82M | $52M | $44M | $23M | $29M | $17M | $22M | · | |
| Long-term Debt | $40M | $29M | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $40M | $29M | · | · | · | · | · | · | $302.0K | · | · | · | |
| Common Stock | $9.0K | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $657M | $630M | $584M | $566M | $552M | $537M | $448M | $387M | $340M | $311M | $306M | $302M | |
| Retained Earnings | $-607M | $-563M | $-498M | $-421M | $-388M | $-366M | $-342M | $-330M | $-315M | $-292M | $-284M | $-276M | |
| AOCI | $8.0K | $52.0K | $0 | · | · | · | · | $0 | $-472.0K | $0 | $405.0K | $-142.0K | |
| Stockholders' Equity | $51M | $67M | $87M | $145M | $164M | $170M | $106M | $56M | $25M | $19M | $23M | $26M | |
| Liabilities + Equity | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Shares Outstanding | 90,478,000 | 81,850,000 | 69,905,000 | 65,811,000 | 65,109,000 | 64,283,000 | 58,877,000 | 54,065,000 | 48,365,000 | 41,255,000 | 40,343,000 | 39,563,000 |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $10M | $13M | $10M | $15M | $12M | $8M | $7M | $8M | $7M | $6M | $5M | $5M | |
| Deferred Tax | $-3.0K | $-2.0K | $0 | $-7.0K | $-9.0K | $-8.0K | $-6.0K | $-29.0K | $12.0K | $-31.0K | $-330.0K | $110.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $0 | $3M | $3M | $3M | |
| Restructuring | $3M | $0 | $3M | $3M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $10M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-49M | $-53M | $11M | $-14M | $-16M | $-13M | $-14M | $-9M | $-2M | $-433.0K | $321.0K | |
| CapEx | $4M | $4M | $4M | $8M | $14M | $4M | $4M | $3M | $985.0K | $888.0K | $1M | $302.0K | |
| Investing Cash Flow | $24M | $-57M | $-5M | $-14M | $-21M | $-6M | $-4M | $-3M | $-983.0K | $-846.0K | $-1M | $5M | |
| Debt Issued | $10M | $30M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $10M | $30M | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $17M | $31M | $9M | $0 | $0 | $86M | $0 | $37M | $24M | $0 | $0 | $9.0K | |
| Net Stock Activity | $17M | $31M | $9M | $0 | $0 | $86M | $50M | · | $24M | $0 | $0 | $9.0K | |
| Financing Cash Flow | $28M | $61M | $8M | $-575.0K | $4M | $81M | $54M | $39M | $22M | $-490.0K | $-2M | $-611.0K | |
| Net Change in Cash | $32M | $-46M | $-49M | $-3M | $-32M | $59M | $38M | $22M | $12M | $-3M | $-3M | $4M | |
| Taxes Paid | · | $17.0K | $194.0K | $100.0K | $102.0K | $312.0K | $5.0K | $5.0K | $32.0K | $5.0K | $8.0K | $15.0K | |
| Free Cash Flow | $-24M | $-54M | $-57M | $3M | $-28M | $-20M | $-16M | $-17M | $-10M | $-4M | $-2M | $19.0K |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| Net Margin | -62.5% | -110.0% | -108.7% | -24.2% | -20.3% | -34.8% | -17.4% | -17.9% | -46.0% | -17.5% | -18.1% | -54.0% | |
| Pretax Margin | -62.4% | -109.9% | -108.6% | -24.0% | -20.1% | -34.3% | -17.4% | -18.0% | -45.8% | -17.6% | -18.9% | -54.7% | |
| EBITDA Margin | -51.8% | -90.3% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| ROA | -29.6% | -45.7% | -39.4% | -13.5% | -9.1% | -13.0% | -10.4% | -16.4% | -51.5% | -21.3% | -16.3% | -35.7% | |
| ROE | -82.8% | -93.0% | -85.6% | -22.5% | -12.8% | -18.4% | -11.5% | -19.6% | -98.6% | -40.8% | -30.8% | -56.3% | |
| ROIC | -46.1% | -61.1% | -78.7% | -24.3% | -13.9% | -14.3% | -11.9% | -20.0% | -92.8% | -44.6% | -32.5% | -71.7% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 | 7.4 | 7.4 | 3.8 | 1.8 | 2.2 | 2.2 | 2.4 | |
| Quick Ratio | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 | 6.5 | 6.5 | 3.6 | 1.7 | 2.0 | 2.1 | 2.2 | |
| Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · | |
| LT Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.6 | 0.9 | 1.1 | 1.2 | 0.9 | 0.7 | |
| Inventory Turnover | 5.2 | 7.3 | 5.4 | 23.9 | 20.9 | 20.6 | 32.6 | 15.5 | 15.4 | 10.7 | 5.5 | 6.7 | |
| Receivables Turnover | · | · | 3.3 | 4.9 | 5.4 | 6.0 | 6.7 | 5.3 | 5.6 | 7.4 | 7.5 | 7.6 |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 18.6% | -15.4% | -49.4% | 32.3% | 51.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -20.2% | -17.3% | 0.52% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.38% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Net Income TTM | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Market Cap | $147M | $390M | $213M | $307M | $2.04B | $1.40B | $941M | $912M | $404M | $190M | $171M | $100M | |
| Enterprise Value | $109M | $346M | · | · | · | · | · | · | $373M | · | · | · | |
| P/E | -3.3 | -5.4 | -2.7 | -9.1 | -94.8 | -54.6 | -76.1 | · | · | · | · | · | |
| P/S | 2.1 | 6.6 | 3.0 | 2.2 | 19.4 | 20.3 | 13.8 | 15.0 | 8.1 | 3.9 | 4.1 | 2.8 | |
| P/B | 2.9 | 5.8 | 2.5 | 2.1 | 12.4 | 8.2 | 8.9 | 16.2 | 16.5 | 9.9 | 7.5 | 3.8 | |
| P / Tangible Book | 3.1 | 6.1 | 2.5 | 2.2 | 12.6 | 8.4 | · | · | · | · | · | · | |
| P / Cash Flow | -7.6 | -7.9 | -4.1 | 27.2 | -142.7 | -85.2 | -75.0 | -64.7 | -46.1 | -70.3 | -394.1 | 310.6 | |
| P / FCF | -6.2 | -7.3 | -3.7 | 103.0 | -72.5 | -69.4 | -57.8 | -54.1 | -41.4 | -52.9 | -104.6 | 5247.3 | |
| EV / EBITDA | -3.0 | -6.5 | · | · | · | · | · | · | -16.2 | · | · | · | |
| EV / FCF | -4.6 | -6.4 | · | · | · | · | · | · | -38.3 | · | · | · | |
| EV / Revenue | 1.6 | 5.8 | · | · | · | · | · | · | 7.5 | · | · | · | |
| Earnings Yield | -30.7% | -18.7% | -36.7% | -10.9% | -1.1% | -1.8% | -1.3% | · | · | · | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $15M | $39M | $9M | $15M | $8M | $21M | $13M | $8M | $17M | $27M | $9M | $21M | $13M | $30M | $34M | |
| Cost of Revenue | $4M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $3M | $5M | $3M | $2M | $3M | $5M | $8M | $10M | |
| R&D Expense | $12M | $11M | $12M | $14M | $14M | $13M | $12M | $12M | $11M | $11M | $11M | $14M | $17M | $17M | $20M | $22M | |
| SG&A Expense | $11M | $10M | $11M | $11M | $12M | $12M | $13M | $14M | $16M | $13M | $12M | $12M | $13M | $15M | $12M | $13M | |
| Operating Expenses | $26M | $23M | $28M | $28M | $28M | $28M | $29M | $29M | $31M | $29M | $26M | $41M | $34M | $37M | $44M | $45M | |
| Operating Income | $-11M | $-8M | $11M | $-19M | $-13M | $-20M | $-7M | $-17M | $-23M | $-12M | $282.0K | $-32M | $-13M | $-24M | $-13M | $-11M | |
| Interest Income | $535.0K | $665.0K | $656.0K | $634.0K | $584.0K | $751.0K | $940.0K | $849.0K | $972.0K | $909.0K | $906.0K | $1M | $1M | $1M | $823.0K | $436.0K | |
| Other Non-op | $-1M | $-1M | $-2M | $-1M | $-984.0K | $-942.0K | $-4M | $-5M | $-985.0K | $-516.0K | $-8M | $-4M | $-9.0K | $-25.0K | $-26.0K | $216.0K | |
| Pretax Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-11M | $-7M | $-35M | $-12M | $-23M | $-12M | $-10M | |
| Income Tax | $10.0K | $36.0K | $18.0K | $8.0K | $10.0K | $11.0K | $4.0K | $10.0K | $10.0K | $10.0K | $35.0K | $9.0K | $9.0K | $16.0K | $151.0K | $8.0K | |
| Net Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-12M | $-7M | $-35M | $-12M | $-23M | $-13M | $-10M | |
| EPS (Basic) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| EPS (Diluted) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| Shares (Basic) | 91,053,000 | 90,768,000 | -170,908,000 | 90,251,000 | 85,389,000 | 82,410,000 | -138,854,000 | 72,032,000 | 70,376,000 | 69,854,000 | -134,839,000 | 69,466,000 | 67,573,000 | 65,931,000 | -130,466,000 | 65,426,000 | |
| Shares (Diluted) | 91,053,000 | 90,768,000 | -170,908,000 | 90,251,000 | 85,389,000 | 82,410,000 | -138,854,000 | 72,032,000 | 70,376,000 | 69,854,000 | -134,839,000 | 69,466,000 | 67,573,000 | 65,931,000 | -130,466,000 | 65,426,000 | |
| EBITDA | $-11M | · | · | $-19M | $-13M | $-19M | · | $-17M | $-23M | $-12M | · | $-32M | $-13M | $-24M | · | $-11M |
Bilanço 27
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $37M | $51M | $25M | $27M | $18M | $19M | $37M | $19M | $58M | $65M | $75M | $92M | $103M | $114M | $109M | |
| Short-term Investments | $28M | $29M | $27M | $33M | $40M | $41M | $54M | $53M | $55M | $27M | · | · | · | · | · | · | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Prepaid Expense | $3M | $4M | $6M | $5M | $3M | $4M | $4M | $3M | $3M | $5M | · | $5M | $4M | $5M | · | $5M | |
| Other Current Assets | $500.0K | $400.0K | $500.0K | $500.0K | $100.0K | $500.0K | $500.0K | $300.0K | $900.0K | $500.0K | · | · | · | · | · | · | |
| Current Assets | $72M | $80M | $97M | $76M | $89M | $78M | $99M | $113M | $91M | $108M | · | $103M | $120M | $130M | · | $146M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $14M | $13M | $14M | $15M | · | $15M | $23M | $24M | · | $23M | |
| PP&E (Gross) | $59M | $59M | $58M | $58M | $58M | $57M | $55M | $54M | $54M | $55M | · | $54M | $66M | $65M | · | $63M | |
| Accum. Depreciation | $47M | $46M | $45M | $44M | $43M | $42M | $41M | $41M | $40M | $40M | · | $39M | $42M | $41M | · | $39M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $1M | $994.0K | $883.0K | $912.0K | $950.0K | $967.0K | $1M | $2M | $2M | $1M | · | $726.0K | $498.0K | $415.0K | · | $208.0K | |
| Total Assets | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $1M | $6M | $3M | $4M | $4M | $3M | · | $3M | $4M | $4M | · | $3M | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $3M | $5M | $6M | $7M | $5M | $5M | · | $9M | $7M | $8M | · | $13M | |
| Current Liabilities | $24M | $15M | $25M | $18M | $15M | $21M | $24M | $35M | $31M | $29M | · | $38M | $36M | $38M | · | $32M | |
| Capital Leases | $28M | $29M | $30M | $26M | $27M | $27M | $28M | $9M | $10M | $11M | · | $13M | $35M | $37M | · | $40M | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $87M | $86M | $97M | $85M | $83M | $79M | $82M | $75M | $71M | $70M | · | $63M | $83M | $92M | · | $81M | |
| Long-term Debt | $41M | $40M | $40M | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Total Debt | $41M | · | · | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $660M | $659M | $657M | $655M | $652M | $633M | $630M | $626M | $593M | $588M | · | $582M | $580M | $570M | · | $563M | |
| Retained Earnings | $-627M | $-615M | $-607M | $-616M | $-597M | $-583M | $-563M | $-552M | $-532M | $-509M | · | $-490M | $-455M | $-444M | · | $-409M | |
| AOCI | $-13.0K | $-11.0K | $8.0K | $12.0K | $-3.0K | $14.0K | $52.0K | $126.0K | $-23.0K | $-16.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $33M | $43M | $51M | $39M | $56M | $50M | $67M | $73M | $61M | $79M | $87M | $92M | $124M | $126M | $145M | $154M | |
| Liabilities + Equity | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Shares Outstanding | 91,388,000 | 90,894,000 | 90,478,000 | 90,281,000 | 90,254,000 | 82,841,000 | 81,850,000 | 81,376,000 | 70,914,000 | 70,554,000 | · | 69,827,000 | 69,804,000 | 66,696,000 | · | 65,613,000 |
Nakit Akışı 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | |
| Stock-based Comp | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $3M | $5M | $3M | $2M | $2M | $3M | $3M | $3M | $5M | |
| Restructuring | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $3M | $72.0K | $72.0K | $3M | $0 | |
| Other Non-cash | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $-13M | $20M | $-8M | $-18M | $-14M | $-16M | $-13M | $-12M | $-8M | $-11M | $-16M | $-16M | $-9M | $5M | $20M | |
| CapEx | $898.0K | $176.0K | $520.0K | $182.0K | $3M | $1M | $2M | $1M | $395.0K | $1M | $-380.0K | $678.0K | $2M | $3M | $-33.0K | $1M | |
| Investing Cash Flow | $175.0K | $-1M | $6M | $6M | $-367.0K | $12M | $-3M | $2M | $-27M | $-29M | $1M | $-1M | $-2M | $-3M | $33.0K | $-1M | |
| Debt Issued | · | · | $0 | $0 | $10M | $0 | $0 | $0 | $0 | $30M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $30M | · | · | · | · | · | · | |
| Stock Issued | · | · | $-1.0K | $0 | · | · | $-1.0K | $31M | $0 | $0 | $0 | $0 | $7M | $2M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $2M | · | · | |
| Financing Cash Flow | $66.0K | $-14.0K | $180.0K | $-111.0K | $27M | $1M | $1M | $30M | $-197.0K | $29M | $0 | $-108.0K | $7M | $1M | $339.0K | $133.0K | |
| Net Change in Cash | $-9M | $-14M | $26M | $-1M | $8M | $-944.0K | $-18M | $19M | $-39M | $-7M | $-10M | $-18M | $-11M | $-11M | $5M | $19M | |
| Taxes Paid | · | · | · | · | · | $0 | · | · | · | $17.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | $-9M | · | · | · | $-12M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -75.3% | · | · | -220.3% | -83.9% | -271.6% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| Net Margin | -80.5% | · | · | -228.1% | -86.6% | -274.3% | · | -160.8% | -285.2% | -67.4% | · | -376.3% | -54.0% | -174.2% | · | -29.0% | |
| Pretax Margin | -80.4% | · | · | -228.0% | -86.5% | -274.1% | · | -160.8% | -285.1% | -67.3% | · | -376.2% | -54.0% | -174.1% | · | -29.0% | |
| EBITDA Margin | -75.3% | · | · | -220.3% | -83.9% | -255.8% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| ROA | -9.3% | · | · | -14.4% | -9.8% | -14.9% | · | -13.6% | -13.4% | -6.3% | · | -17.9% | -5.2% | -10.0% | · | -4.3% | |
| ROE | -27.1% | · | · | -35.0% | -22.7% | -32.1% | · | -25.0% | -24.5% | -11.2% | · | -28.4% | -8.1% | -15.9% | · | -6.2% | |
| ROIC | -15.2% | · | · | -24.2% | -13.6% | -26.0% | · | -16.2% | -25.3% | -11.1% | · | -35.0% | -10.2% | -18.8% | · | -6.9% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 4.1 | 5.8 | 3.7 | · | 3.2 | 3.0 | 3.7 | · | 2.7 | 3.4 | 3.4 | · | 4.6 | |
| Quick Ratio | 2.3 | · | · | 3.2 | 4.4 | 2.9 | · | 2.6 | 2.4 | 2.9 | · | 1.9 | 2.6 | 2.7 | · | 3.4 | |
| Debt / Equity | 1.2 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · | |
| LT Debt / Equity | 1.0 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.1 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 2.0 | · | · | 1.2 | 1.0 | 1.3 | · | 2.0 | 1.6 | 2.2 | · | 1.1 | 1.7 | 2.5 | · | 7.2 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $47M | · | $44M | $44M | $45M | · | $47M | $56M | $61M | · | $78M | $107M | $121M | · | $145M | |
| Net Income TTM | $-54M | $-62M | · | $-74M | $-77M | $-76M | · | $-90M | $-81M | $-81M | · | $-79M | $-47M | $-44M | · | $-19M | |
| Market Cap | $207M | · | · | $220M | $220M | $223M | · | $251M | $220M | $246M | · | $132M | $195M | $276M | · | $398M | |
| Enterprise Value | $192M | · | · | $201M | $193M | $192M | · | $189M | $175M | $189M | · | · | · | · | · | · | |
| P/E | -3.7 | -2.2 | · | -2.7 | -2.4 | -2.6 | · | -2.4 | -2.7 | -3.0 | · | -1.6 | -4.0 | -6.3 | · | -20.9 | |
| P/S | 3.8 | · | · | 5.0 | 5.0 | 4.9 | · | 5.3 | 4.0 | 4.1 | · | 1.7 | 1.8 | 2.3 | · | 2.7 | |
| P/B | 6.3 | · | · | 5.7 | 4.0 | 4.5 | · | 3.4 | 3.6 | 3.1 | · | 1.4 | 1.6 | 2.2 | · | 2.6 | |
| P / Tangible Book | 6.8 | 3.6 | · | 6.1 | 4.1 | 4.7 | · | 3.5 | 3.7 | 3.2 | · | 1.5 | 1.6 | 2.2 | · | 2.6 | |
| P / Cash Flow | · | · | · | · | · | -16.2 | · | · | · | -31.6 | · | · | · | -30.0 | · | · | |
| P / FCF | · | · | · | · | · | -14.8 | · | · | · | -27.6 | · | · | · | -23.5 | · | · | |
| EV / EBITDA | -17.1 | · | · | -10.6 | -15.0 | -10.0 | · | -11.4 | -7.7 | -15.9 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -12.8 | · | · | · | -21.2 | · | · | · | · | · | · | |
| EV / Revenue | 3.6 | · | · | 4.5 | 4.4 | 4.2 | · | 4.0 | 3.1 | 3.1 | · | · | · | · | · | · | |
| Earnings Yield | -27.0% | -44.8% | · | -37.7% | -41.8% | -37.9% | · | -41.2% | -37.1% | -33.5% | · | -61.4% | -25.0% | -15.9% | · | -4.8% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $70M | $59M | $70M | $139M | $105M |
| Faaliyet Kâr Marjı % | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% |
| Net Gelir | $-44M | $-65M | $-76M | $-34M | $-21M |
| Seyreltilmiş Hisse Başı Kâr | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.8 | 0.4 | — | — | — |
| Cari Oran | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 |
| Cari Oran | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-24M | $-54M | $-57M | $3M | $-28M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 156 dosya · $120.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 32 (+4 önceki Ç'ye göre) | 11 (-10 önceki Ç'ye göre) | 50 (+4 önceki Ç'ye göre) | 41 (+8 önceki Ç'ye göre) | +6.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Opaleye Management Inc. | $15.334.100 | 6.785.000 | 12,69% | Hisse senetleri |
| Aberdeen Group plc | $15.300.096 | 6.769.954 | 12,66% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $12.541.054 | 5.549.139 | 10,38% | Hisse senetleri |
| Telemark Asset Management, LLC | $8.692.889 | 3.846.411 | 7,19% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $8.609.334 | 3.809.440 | 7,12% | Hisse senetleri |
| Nantahala Capital Management, LLC | $8.189.365 | 3.623.613 | 6,78% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.174.666 | 3.617.109 | 6,76% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $4.204.899 | 1.860.140 | 3,48% | Hisse senetleri |
| STATE STREET CORP | $3.970.400 | 1.756.814 | 3,29% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.006.263 | 1.330.205 | 2,49% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.954.206 | 1.307.171 | 2,44% | Hisse senetleri |
| Assenagon Asset Management S.A. | $2.888.746 | 1.278.206 | 2,39% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $2.500.229 | 1.106.296 | 2,07% | Hisse senetleri |
| Tallon Kerry Patrick | $2.018.337 | 403.667 | 1,67% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.574.314 | 696.599 | 1,30% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $1.533.726 | 678.640 | 1,27% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $1.313.191 | 581.058 | 1,09% | Hisse senetleri |
| Man Group plc | $1.278.240 | 565.593 | 1,06% | Hisse senetleri |
| Post Resch Tallon Group Inc. | $1.273.460 | 563.478 | 1,05% | Hisse senetleri |
| PERKINS CAPITAL MANAGEMENT INC | $1.188.986 | 526.100 | 0,98% | Hisse senetleri |
| ALGERT GLOBAL LLC | $973.857 | 430.910 | 0,81% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $808.910 | 357.925 | 0,67% | Hisse senetleri |
| BlackRock, Inc. | $648.681 | 287.027 | 0,54% | Hisse senetleri |
| PLATINUM INVESTMENT MANAGEMENT LTD | $597.689 | 264.464 | 0,49% | Hisse senetleri |
| Potomac Capital Management, Inc. | $587.600 | 260.000 | 0,49% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $583.674 | 258.263 | 0,48% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $547.397 | 242.211 | 0,45% | Hisse senetleri |
| XTX Topco Ltd | $543.817 | 240.627 | 0,45% | Hisse senetleri |
| UBS Group AG | $542.188 | 239.906 | 0,45% | Hisse senetleri |
| FMR LLC | $457.501 | 202.434 | 0,38% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $389.726 | 172.445 | 0,32% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $359.610 | 147.381 | 0,30% | Hisse senetleri |
| BARCLAYS PLC | $347.740 | 153.867 | 0,29% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $334.595 | 148.051 | 0,28% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $284.552 | 125.908 | 0,24% | Hisse senetleri |
| STRS OHIO | $273.460 | 121.000 | 0,23% | Hisse senetleri |
| JANE STREET GROUP, LLC | $261.857 | 115.866 | 0,22% | Hisse senetleri |
| MARSHALL WACE, LLP | $254.791 | 112.739 | 0,21% | Hisse senetleri |
| Stonepine Capital Management, LLC | $247.836 | 109.662 | 0,21% | Hisse senetleri |
| RHUMBLINE ADVISERS | $233.449 | 103.301 | 0,19% | Hisse senetleri |
| CITADEL ADVISORS LLC | $227.295 | 100.573 | 0,19% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $206.081 | 126.430 | 0,17% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $176.113 | 77.926 | 0,15% | Hisse senetleri |
| Bank of New York Mellon Corp | $174.178 | 77.070 | 0,14% | Hisse senetleri |
| LPL Financial LLC | $173.026 | 76.560 | 0,14% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $161.879 | 71.628 | 0,13% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $145.582 | 64.417 | 0,12% | Hisse senetleri |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $144.082 | 63.753 | 0,12% | Hisse senetleri |
| Numerai GP LLC | $136.072 | 60.209 | 0,11% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $131.532 | 58.200 | 0,11% | Hisse senetleri |
| Mariner, LLC | $123.484 | 54.637 | 0,10% | Hisse senetleri |
| MetLife Investment Management, LLC | $117.545 | 52.011 | 0,10% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $116.108 | 51.375 | 0,10% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $108.763 | 48.125 | 0,09% | Hisse senetleri |
| IEQ CAPITAL, LLC | $104.559 | 46.265 | 0,09% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $96.822 | 59.400 | 0,08% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $93.790 | 41.500 | 0,08% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $89.957 | 39.804 | 0,07% | Hisse senetleri |
| CITIGROUP INC | $86.660 | 38.345 | 0,07% | Hisse senetleri |
| Frec Markets, Inc. | $84.228 | 37.269 | 0,07% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $82.186 | 36.366 | 0,07% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $81.820 | 36.204 | 0,07% | Hisse senetleri |
| BANK OF MONTREAL /CAN/ | $79.095 | 34.998 | 0,07% | Hisse senetleri |
| Krilogy Financial LLC | $78.705 | 34.825 | 0,07% | Hisse senetleri |
| MORGAN STANLEY | $77.462 | 34.275 | 0,06% | Hisse senetleri |
| Invesco Ltd. | $77.181 | 34.151 | 0,06% | Hisse senetleri |
| Dynamic Technology Lab Private Ltd | $74.000 | 33.000 | 0,06% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $73.681 | 32.602 | 0,06% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $73.111 | 32.350 | 0,06% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $68.932 | 30.501 | 0,06% | Hisse senetleri |
| BLAIR WILLIAM & CO/IL | $68.295 | 30.219 | 0,06% | Hisse senetleri |
| EVERGREEN CAPITAL MANAGEMENT LLC | $65.540 | 29.000 | 0,05% | Hisse senetleri |
| CWM, LLC | $63.696 | 39.077 | 0,05% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $61.418 | 25.275 | 0,05% | Hisse senetleri |
| Nuveen Asset Management, LLC | $59.902 | 12.558 | 0,05% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $59.619 | 26.380 | 0,05% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56.963 | 25.205 | 0,05% | Hisse senetleri |
| Cerity Partners LLC | $53.695 | 23.759 | 0,04% | Hisse senetleri |
| VANGUARD GROUP INC | $53.141 | 32.602 | 0,04% | Hisse senetleri |
| INTECH INVESTMENT MANAGEMENT LLC | $48.486 | 21.454 | 0,04% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $45.426 | 20.100 | 0,04% | Alım opsiyonu |
| Police & Firemen's Retirement System of New Jersey | $43.937 | 19.441 | 0,04% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $41.948 | 18.561 | 0,03% | Hisse senetleri |
| Vanguard Personalized Indexing Management, LLC | $40.562 | 17.948 | 0,03% | Hisse senetleri |
| Simplicity Wealth,LLC | $39.410 | 17.438 | 0,03% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $38.167 | 16.888 | 0,03% | Hisse senetleri |
| CITADEL ADVISORS LLC | $35.708 | 15.800 | 0,03% | Alım opsiyonu |
| Creative Planning | $35.003 | 15.488 | 0,03% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $34.942 | 15.461 | 0,03% | Hisse senetleri |
| Navalign, LLC | $34.668 | 15.340 | 0,03% | Hisse senetleri |
| EP Wealth Advisors, LLC | $34.526 | 15.277 | 0,03% | Hisse senetleri |
| China Universal Asset Management Co., Ltd. | $32.693 | 14.466 | 0,03% | Hisse senetleri |
| ProShare Advisors LLC | $32.324 | 14.303 | 0,03% | Hisse senetleri |
| Elmwood Wealth Management, Inc. | $28.691 | 12.695 | 0,02% | Hisse senetleri |
| NORTHERN TRUST CORP | $27.992 | 12.386 | 0,02% | Hisse senetleri |
| OXFORD ASSET MANAGEMENT LLP | $27.335 | 12.095 | 0,02% | Hisse senetleri |
| Graham Capital Management, L.P. | $27.287 | 12.074 | 0,02% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $27.244 | 12.055 | 0,02% | Hisse senetleri |
| Abel Hall, LLC | $26.930 | 11.916 | 0,02% | Hisse senetleri |
| Caerus Investment Advisors, LLC | $26.297 | 11.636 | 0,02% | Hisse senetleri |
Şirket yöneticileri 40 içeriden öğrenenler · 19 yöneticiler · 20 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| John J Nicols | President and CEO | 11 Haziran 2018 M | 1.072.679 | 0 | 0 | $0 |
| Peter M Strumph | Interim President and CEO | 01 Haziran 2012 A | 60.756 | 0 | 0 | $0 |
| Alan Shaw | President and CEO | 16 Aralık 2011 S | 202.000 | 0 | 0 | $0 |
| Georgia Erbez | Chief Financial Officer | 05 Şubat 2025 A | 76.875 | 0 | 0 | $0 |
| Sriram Ryali | Chief Financial Officer | 01 Ocak 2024 A | 175.791 | 0 | 0 | $0 |
| Gordon Sangster | SVP & Chief Financial Officer | 24 Mayıs 2018 S | 153.189 | 0 | 0 | $0 |
| David D O'Toole | SVP & Chief Financial Officer | 04 Eylül 2013 F | 110.687 | 0 | 0 | $0 |
| Brian Paul Dowd | Interim CFO | 01 Haziran 2012 A | 28.310 | 0 | 0 | $0 |
| Robert J Lawson | SVP and CFO | 11 Mayıs 2011 P | 44.000 | 0 | 0 | $0 |
| Kevin Norrett | Chief Operating Officer | 05 Şubat 2025 A | 177.327 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | 05 Şubat 2025 A | 175.571 | 0 | 0 | $0 |
| Margaret Nell Fitzgerald | Chief Legal and Compliance Officer | 01 Ocak 2024 A | 133.770 | 0 | 0 | $0 |
| James Lalonde | SVP, R&D | 17 Temmuz 2018 S | 195.066 | 0 | 0 | $0 |
| Michael D. Aldridge | Senior Vice President, Corporate & Strategic Development | 17 Mayıs 2018 M | 0 | 0 | 0 | $0 |
| Douglas T. Sheehy | EVP, Chief Administrative Officer, General Counsel & Secretary | 05 Mart 2016 F | 247.617 | 0 | 0 | $0 |
| Matthew Tobin | SVP, Research & Development | 16 Mayıs 2013 M | 78.707 | 0 | 0 | $0 |
| David L. Anton | SVP, BioIndustrials | 10 Şubat 2013 F | 93.777 | 0 | 0 | $0 |
| Seufer-Wasserthal Peter | SVP, Pharmaceuticals | 24 Ocak 2013 A | 93.064 | 0 | 0 | $0 |
| Joseph J. Sarret | SVP and CBO | 07 Mart 2012 A | 74.000 | 0 | 0 | $0 |
| Raymond De Vre | Yönetim kurulu üyesi | 17 Haziran 2026 A | 84.811 | 0 | 1 | $-6.174 |
| Esther Martinborough | Yönetim kurulu üyesi | 17 Haziran 2026 A | 129.036 | 0 | 0 | $0 |
| Christos Richards | Yönetim kurulu üyesi | 17 Haziran 2026 A | 85.133 | 0 | 0 | $0 |
| Cynthia Collins | Yönetim kurulu üyesi | 17 Haziran 2026 A | 112.157 | 0 | 0 | $0 |
| Stephen George Dilly | Yönetim kurulu üyesi | 17 Haziran 2026 A | 673.053 | 0 | 0 | $0 |
| Rahul Singhvi | Yönetim kurulu üyesi | 17 Haziran 2026 A | 137.052 | 0 | 0 | $0 |
| David V Smith | Yönetim kurulu üyesi | 17 Haziran 2026 A | 105.705 | 0 | 0 | $0 |
| PARKER H STEWART | Yönetim kurulu üyesi | 17 Haziran 2026 A | 143.583 | 0 | 0 | $0 |
| Dennis P Wolf | Yönetim kurulu üyesi | 10 Haziran 2025 A | 147.903 | 0 | 0 | $0 |
| Byron L Dorgan | Yönetim kurulu üyesi | 11 Haziran 2024 A | 223.581 | 0 | 0 | $0 |
| Patrick Y Yang | Yönetim kurulu üyesi | 19 Temmuz 2018 S | 304.157 | 0 | 0 | $0 |
| Kathleen Sereda Glaub | Yönetim kurulu üyesi | 18 Temmuz 2018 S | 98.120 | 0 | 0 | $0 |
| Thomas R Baruch | Yönetim kurulu üyesi | 26 Haziran 2018 S | 153.093 | 0 | 0 | $0 |
| Bernard J Kelley | Yönetim kurulu üyesi | 21 Haziran 2018 S | 225.668 | 0 | 0 | $0 |
| Pam P. Cheng | Yönetim kurulu üyesi | 11 Haziran 2018 A | 64.642 | 0 | 0 | $0 |
| Alexander Karsner | Yönetim kurulu üyesi | 02 Ocak 2014 A | 78.519 | 0 | 0 | $0 |
| Bruce A Pasternack | Yönetim kurulu üyesi | 24 Ağustos 2010 P | 10.000 | 0 | 0 | $0 |
| James R Sulat | Yönetim kurulu üyesi | 27 Nisan 2010 J | 5.957.108 | 0 | 0 | $0 |
| Brazil Holding B.V. Shell | 10% sahip | 31 Mayıs 2011 J | 5.573.319 | 0 | 0 | $0 |
| Equilon Enterprises LLC | 10% sahip | 20 Mayıs 2011 J | 5.573.319 | 0 | 0 | $0 |
| MAXYGEN INC | 10% sahip | 14 Aralık 2010 J | 524.643 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| John Nicols | 16 Şubat 2021 | — | İlk başvuru | — | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAÍZEN ENERGIA S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON SHELL BRAZIL HOLDING B.V., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COMÉRCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN INVESTIMENTOS E PARTICIPAÇÕES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED ×2 başvurular | 26 Mayıs 2015 | — | İlk başvuru | — | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAIZEN ENERGIA PARTICIPA Ç Õ ES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ISPAGNAC PARTICIPA Ç Õ ES LTDA., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COM É RCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED | 07 Haziran 2011 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 26 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,26% | 40.370 SH | 08 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,03% | 290.804 SH | 08 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,01% | 3.341 NS | 31 Mayıs 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 496.936 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 78.444 SH | 08 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,01% | 613.531 SH | 08 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 4.900 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 38.712 NS | 30 Nisan 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 679.206 SH | 08 Ağustos 2026 | Günlük |
| ITWO · ProShares Trust | 0,01% | 4.198 NS | 31 Mayıs 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 2.240.076 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,00% | 3.283 NS | 31 Mayıs 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 71.405 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28.868 NS | 31 Mayıs 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 3.320 NS | 31 Mayıs 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 128.823 SH | 08 Ağustos 2026 | Günlük |
| HDG · ProShares Trust | 0,00% | 83 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 52.788 NS | 30 Nisan 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.554 NS | 31 Mayıs 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.729 NS | 30 Nisan 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.926 SH | 08 Ağustos 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 19.277 NS | 30 Nisan 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 895.869 SH | 08 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.633.770 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.454 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.744 SH | 08 Ağustos 2026 | Günlük |